From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
… Here, we will highlight prime examples of lncRNAs that serve as marker for cancer
progression or therapy response and which might represent promising therapeutic targets. …
progression or therapy response and which might represent promising therapeutic targets. …
The promise and perils of immunotherapy
… of powerful therapeutic strategies to treat these diseases. In contrast to conventional therapies
that … are more akin to targeted therapies because they are mechanistically driven and are …
that … are more akin to targeted therapies because they are mechanistically driven and are …
Targeting the p53 signaling pathway in cancer therapy–the promises, challenges and perils
AH Stegh - Expert opinion on therapeutic targets, 2012 - Taylor & Francis
Introduction: Research over the past three decades has identified p53 as a multi-functional
transcription factor. p53 influences myriad, highly diverse cellular processes, and represents …
transcription factor. p53 influences myriad, highly diverse cellular processes, and represents …
Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
D Torti, L Trusolino - EMBO molecular medicine, 2011 - embopress.org
… enrich the catalogue of therapeutic targets, the task of developing therapies suitable for
successful … Yet, the success of therapies that target specific oncoproteins in molecularly defined …
successful … Yet, the success of therapies that target specific oncoproteins in molecularly defined …
The promise and peril of targeting cell metabolism for cancer therapy
JM Weiss - Cancer Immunology, Immunotherapy, 2020 - Springer
… itaconate production in resident macrophages remain to be determined, this metabolite
facilitates tumor progression in the peritoneal cavity and may represent a novel therapeutic target …
facilitates tumor progression in the peritoneal cavity and may represent a novel therapeutic target …
The promise and perils of 'targeted therapy'of advanced ovarian cancer
M Markman - Oncology, 2008 - karger.com
… of ‘targeted’ therapy in ovarian cancer will focus on molecular targets of documented relevance
… However, the relevance of HER-2 as a molecular therapeutic target in epithelial ovarian …
… However, the relevance of HER-2 as a molecular therapeutic target in epithelial ovarian …
The promise and perils of HDAC inhibitors in neurodegeneration
A Didonna, P Opal - Annals of clinical and translational …, 2015 - Wiley Online Library
… Histone deacetylases (HDACs) represent emerging therapeutic targets in the context of …
However, the translation of such therapeutic approach to clinics has been only marginally …
However, the translation of such therapeutic approach to clinics has been only marginally …
Perils and promises of therapeutic approaches for the stem cell disease fibrous dysplasia
I Saggio - Stem Cells Translational Medicine, 2019 - academic.oup.com
… deacetylase 8 (HDCA8), a zinc-dependent HDAC subtype, as potential therapeutic target for
FD. … HDAC8, a potential therapeutic target, regulates proliferation and differentiation of bone …
FD. … HDAC8, a potential therapeutic target, regulates proliferation and differentiation of bone …
The promise and peril of chemical probe negative controls
J Lee, M Schapira - ACS chemical biology, 2021 - ACS Publications
… function and discover therapeutic targets. Chemical probe off-targets are a confounding factor
as the observed phenotype may be driven by inhibition of an unknown off-target instead of …
as the observed phenotype may be driven by inhibition of an unknown off-target instead of …
Cyclooxygenase‐2 inhibitors: promise or peril?
LJ Mengle-Gaw, BD Schwartz - Mediators of Inflammation, 2002 - Wiley Online Library
… promise that the therapeutic benefits of NSAIDs could be optimized through inhibition of
COX‐2, while minimizing their adverse side effect profile associated with inhibition of COX‐1. …
COX‐2, while minimizing their adverse side effect profile associated with inhibition of COX‐1. …
相关搜索
- promise and peril cancer therapy
- promises and perils oncogene addiction
- hdac inhibitors promise and perils
- promise or peril cyclooxygenase 2 inhibitors
- promises and perils long non-coding rnas
- therapeutic targets long noncoding rnas
- potential therapeutic target
- promise and peril cell metabolism
- therapeutic targets long non-coding rnas
- target for cancer therapy